Abstract
Abstract Dementia is a health problem affecting millions of people worldwide. Its prevalence increases with age and it is almost always a disease of the elderly. It has also been observed that Alzheimer's disease (AD) is the leading cause of dementia. This article reviews MCI and AD trials to derive guidelines on how future trials may be conducted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
